Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Deep Dive: Upper Digestive Cancers – Local Treatment Beyond Surgery of Non-Colorectal Cancers

Live on
09 Mar 2022 at 18:30 CET

It is with great pleasure that we invite you to participate in the second ESMO Deep Dive Webinar: an in-depth exploration of local treatment of non-colorectal cancers beyond surgery.

This instalment will focus on innovative techniques of local treatment of upper gastrointestinal and hepato-pancreatico-biliary malignancies beyond current state-of-the-art clinical practice. We believe this to be a particularly hot topic in the era of immunotherapy, with its implications in redefining the borders between oligometastatic and systemic disease.

The webinar will begin with a brief introduction, followed by three lectures on distinct aspects of the field delivered by international experts, Drs. Matthias Guckenberger, Max Seidensticker and Thierry de Baere. The webinar will conclude with a live discussion of questions submitted by the audience during the lectures.

We invite you and encourage you to register and join us in this new, highly specialised ESMO event.


Magnus Nilsson
MD, PhD Professor of Surgery, Karolinska Institutet, Stockhom, Sweden
Senior Consultant Surgeon, Karolinska University Hospital, Stockhom, Sweden


Jens Ricke
Chair of the Department of Radiology at University Hospital, LMU, Munich






5 min

Welcome and Introduction

Prof. Magnus Nilsson, Prof. Jens Ricke

25 min

Oligometastatic disease: a case for personalised craftsmanship

Matthias Guckenberger

25 min

The toolbox of image guided tumour ablation – a technical rehearsal

Max Seidensticker, Stefanie Corradini

25 min

HCC and CCC: ablation in the era of immunotherapy and molecular tumour boards

Thierry de Baere

15 min



A certificate of attendance and 1 ESMO MORA category point will be awarded for live attendance at this event.

Learning objectives:

  • When to consider local treatments in a metastatic setting
  • Biology considerations for selecting ablative and systemic therapeutic modalities
  • Interventional Radiology and Radiotherapy perspectives on established local ablation approaches
  • Understanding the role of image-guided ablation in primary liver cancer and exploring synergisms with systemic targeted therapies

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.